315 related articles for article (PubMed ID: 35814424)
41. Identification of a necroptosis-related gene signature as a novel prognostic biomarker of cholangiocarcinoma.
Xu L; Gao X; Xing J; Guo Z
Front Immunol; 2023; 14():1118816. PubMed ID: 36936916
[TBL] [Abstract][Full Text] [Related]
42. Development and Validation of a Novel Survival Model for Cutaneous Melanoma Based on Necroptosis-Related Genes.
Niu Z; Wang X; Xu Y; Li Y; Gong X; Zeng Q; Zhang B; Xi J; Pei X; Yue W; Han Y
Front Oncol; 2022; 12():852803. PubMed ID: 35387121
[TBL] [Abstract][Full Text] [Related]
43. Comprehensive Characterization of Cachexia-Inducing Factors in Diffuse Large B-Cell Lymphoma Reveals a Molecular Subtype and a Prognosis-Related Signature.
Kuang Z; Li X; Liu R; Chen S; Tu J
Front Cell Dev Biol; 2021; 9():648856. PubMed ID: 34079795
[TBL] [Abstract][Full Text] [Related]
44. Identification and validation of necroptosis-related gene signatures to predict clinical outcomes and therapeutic responses in acute myeloid leukemia.
Wen XM; Xu ZJ; Ma JC; Xia PH; Jin Y; Chen XY; Qian W; Lin J; Qian J
Aging (Albany NY); 2023 Nov; 15(24):14677-14702. PubMed ID: 37993258
[TBL] [Abstract][Full Text] [Related]
45. Comprehensive Profiling Reveals Prognostic and Immunogenic Characteristics of Necroptosis in Soft Tissue Sarcomas.
Qi L; Xu R; Ren X; Zhang W; Yang Z; Tu C; Li Z
Front Immunol; 2022; 13():877815. PubMed ID: 35663937
[TBL] [Abstract][Full Text] [Related]
46. Identification of necroptosis-related gene signature and characterization of tumour microenvironment infiltration in non-small-cell lung cancer.
Dai J; Fu Y
J Cell Mol Med; 2022 Sep; 26(17):4698-4709. PubMed ID: 35871768
[TBL] [Abstract][Full Text] [Related]
47. Identification of pyroptosis-related signature and development of a novel prognostic model in diffuse large B-cell lymphoma.
Lv L; Zhang Y; Kong R; Wang C; Wang X; Zhou X
J Cancer Res Clin Oncol; 2023 Nov; 149(14):12677-12690. PubMed ID: 37452851
[TBL] [Abstract][Full Text] [Related]
48. Integrative Analysis of Neuregulin Family Members-Related Tumor Microenvironment for Predicting the Prognosis in Gliomas.
Zhao WJ; Ou GY; Lin WW
Front Immunol; 2021; 12():682415. PubMed ID: 34054873
[TBL] [Abstract][Full Text] [Related]
49. Identification of ATP1B1, a key copy number driver gene in diffuse large B-cell lymphoma and potential target for drugs.
Zhang S; Wang H; Liu A
Ann Transl Med; 2022 Oct; 10(20):1136. PubMed ID: 36388804
[TBL] [Abstract][Full Text] [Related]
50. Identification and Validation of a DNA Damage Repair-Related Signature for Diffuse Large B-Cell Lymphoma.
Li Y; Liu X; Chang Y; Fan B; Shangguan C; Chen H; Zhang L
Biomed Res Int; 2022; 2022():2645090. PubMed ID: 36281462
[TBL] [Abstract][Full Text] [Related]
51. Analysis of endoplasmic reticulum stress-related gene signature for the prognosis and pattern in diffuse large B cell lymphoma.
Zhang C; Lin Q; Li C; Chen Z; Deng M; Weng H; Zhu X
Sci Rep; 2023 Aug; 13(1):13894. PubMed ID: 37626099
[TBL] [Abstract][Full Text] [Related]
52. A comprehensive pan-cancer analysis of necroptosis molecules in four gynecologic cancers.
Zheng J; Cai X; Zhang Y; Wang H; Liu L; Tang F; Liu L; Sun Y
BMC Cancer; 2022 Nov; 22(1):1160. PubMed ID: 36357839
[TBL] [Abstract][Full Text] [Related]
53. Comprehensive analysis to identify the neurotransmitter receptor-related genes as prognostic and therapeutic biomarkers in hepatocellular carcinoma.
Wang X; Li Y; Shi Y; Luo J; Zhang Y; Pan Z; Wu F; Tian J; Yu W
Front Cell Dev Biol; 2022; 10():887076. PubMed ID: 35990607
[No Abstract] [Full Text] [Related]
54. A novel angiogenesis-related scoring model predicts prognosis risk and treatment responsiveness in diffuse large B-cell lymphoma.
Liu Y; Wang J; Shen X; Li L; Zhang N; Wang X; Tang B
Clin Exp Med; 2023 Nov; 23(7):3781-3797. PubMed ID: 37402040
[TBL] [Abstract][Full Text] [Related]
55. Hypoxia-related tumor environment correlated with immune infiltration and therapeutic sensitivity in diffuse large B-cell lymphoma.
Liu C; Liu L
Front Genet; 2022; 13():1037716. PubMed ID: 36313435
[No Abstract] [Full Text] [Related]
56. Identification of featured necroptosis-related genes and imbalanced immune infiltration in sepsis
She H; Tan L; Yang R; Zheng J; Wang Y; Du Y; Peng X; Li Q; Lu H; Xiang X; Hu Y; Liu L; Li T
Front Genet; 2023; 14():1158029. PubMed ID: 37091800
[No Abstract] [Full Text] [Related]
57. Integrated Analysis of Necroptosis-Related Genes for Prognosis, Immune Microenvironment Infiltration, and Drug Sensitivity in Colon Cancer.
He R; Zhang M; He L; Huang J; Man C; Wang X; Lang Y; Fan Y
Front Med (Lausanne); 2022; 9():845271. PubMed ID: 35479956
[TBL] [Abstract][Full Text] [Related]
58. Identification of necroptosis-related subtypes, development of a novel signature, and characterization of immune infiltration in colorectal cancer.
Sun M; Ji X; Xie M; Chen X; Zhang B; Luo X; Feng Y; Liu D; Wang Y; Li Y; Liu B; Xia L; Huang W
Front Immunol; 2022; 13():999084. PubMed ID: 36544770
[TBL] [Abstract][Full Text] [Related]
59. Identification of molecular subtypes, risk signature, and immune landscape mediated by necroptosis-related genes in non-small cell lung cancer.
Zhu J; Wang J; Wang T; Zhou H; Xu M; Zha J; Feng C; Shen Z; Jiang Y; Chen J
Front Oncol; 2022; 12():955186. PubMed ID: 35965497
[TBL] [Abstract][Full Text] [Related]
60. A novel prognostic model based on four circulating miRNA in diffuse large B-cell lymphoma: implications for the roles of MDSC and Th17 cells in lymphoma progression.
Sun R; Zheng Z; Wang L; Cheng S; Shi Q; Qu B; Fu D; Leboeuf C; Zhao Y; Ye J; Janin A; Zhao WL
Mol Oncol; 2021 Jan; 15(1):246-261. PubMed ID: 33107145
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
